DarioHealth Corp. (DRIO)
8.20
-0.15
(-1.80%)
USD |
NASDAQ |
May 19, 16:00
8.24
+0.04
(+0.49%)
After-Hours: 20:00
DarioHealth Research and Development Expense (Quarterly) : 2.385M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Retrieve Medical Holdings, Inc. | -- |
| American Well Corp. | 12.38M |
| GoodRx Holdings, Inc. | 30.18M |
| Claritev Corp. | -- |
| Certara, Inc. | 12.29M |